In Non-small cell lung cancer (NSCLC) signaling activates PI3K/Akt promoting VEGF-C/D, MMP-2/9, aTIMP-1/2, and NF-κB, supporting tumor growth, survival and invasion. Here, MMP2 is linked to non-small cell lung carcinoma.